https://www.moneycontrol.com/news/trends/health/study-links-bharat-biotechs-rotovac-to-increased-risk-of-bowel-issues-in-infants-company-defends-safety-report-12749695.html
Bharat Biotech's Rotovac vaccine, part of India's immunisation drive, linked to higher infant intussusception risk in a study published in the International Journal of Risk and Safety in Medicine.
Create an account or login to join the discussion